Prediction of bladder cancer recurrences using artificial neural networks

  • Authors:
  • Ekaitz Zulueta Guerrero;Naiara Telleria Garay;Jose Manuel Lopez-Guede;Borja Ayerdi Vilches;Eider Egilegor Iragorri;David Lecumberri Castaños;Ana Belén de la Hoz Rastrollo;Carlos Pertusa Peña

  • Affiliations:
  • Dpto de Ingeniería de Sistemas y Automática, Escuela Universitaria de Ingeniería, Álava, (Spain);Dominion Pharmakine S.L., Parque Tecnológico de Bizkaia edificio 801A, Derio, Bizkaia, (Spain);Dpto de Ingeniería de Sistemas y Automática, Escuela Universitaria de Ingeniería, Álava, (Spain);Dpto de Ingeniería de Sistemas y Automática, Escuela Universitaria de Ingeniería, Álava, (Spain);Dominion Pharmakine S.L., Parque Tecnológico de Bizkaia edificio 801A, Derio, Bizkaia, (Spain);Servicio Urología, Hospital Cruces, Bizkaia, (Spain);Dominion Pharmakine S.L., Parque Tecnológico de Bizkaia edificio 801A, Derio, Bizkaia, (Spain);Servicio Urología, Hospital Cruces, Bizkaia, (Spain)

  • Venue:
  • HAIS'10 Proceedings of the 5th international conference on Hybrid Artificial Intelligence Systems - Volume Part I
  • Year:
  • 2010

Quantified Score

Hi-index 0.00

Visualization

Abstract

Even if considerable advances have been made in the field of early diagnosis, there is no simple, cheap and non-invasive method that can be applied to the clinical monitorisation of bladder cancer patients Moreover, bladder cancer recurrences or the reappearance of the tumour after its surgical resection cannot be predicted in the current clinical setting In this study, Artificial Neural Networks (ANN) were used to assess how different combinations of classical clinical parameters (stage-grade and age) and two urinary markers (growth factor and pro-inflammatory mediator) could predict post surgical recurrences in bladder cancer patients Different ANN methods, input parameter combinations and recurrence related output variables were used and the resulting positive and negative prediction rates compared MultiLayer Perceptron (MLP) was selected as the most predictive model and urinary markers showed the highest sensitivity, predicting correctly 50% of the patients that would recur in a 2 year follow-up period.